Poster Presentations – Monday, October 20, 10:30 am - 4:00 pmP1018. Hepatitis C (HCV) Treatment Progress and SVR of CombinationTherapy in PracticeNadia El-Hamdi, HSG, Frankie Chen, HSG, Aya Cloyd, HSG, ImtiazAlam, MD, Austin Hepatitis Center, Austin, TXP1019. Incidence of Clip Artifact After Post-Polypectomy Clip Closure ofLarge Colon PolypsGouri Sreepati, MBBS, Krishna Vemulapalli, MBBS, MPH, Douglas Rex,MD, Medicine, Indiana University School of Medicine, Indianapolis, INP1020. Depression and Mortality in Gastrointestinal CancersChukwuemeka Ezeoke, MD, Vivian Nwankwo, PharmD, KaraChristopher, MS, MPH, Christine Hachem, MD, FACG, InternalMedicine, Saint Louis University School of Medicine, St. Louis, MOP1021. Laxative Use Over Time in Patients With Opioid-InducedConstipation for Chronic Non-Cancer PainCatherine Datto, MD, MSc, Robert LoCasale, PhD, MSc, Mary KayMargolis, MPH, MHA, Karen Yeomans, MSc, Krista Payne, MEd, KarinCoyne, PhD, MPH, AstraZeneca Pharmaceuticals, LP, Wilmington,DE, Outcomes Research, Evidera, Bethesda, MD, United BiosourceCorporation, Montreal, QC, CanadaP1022. Concurrent Use of Acid Suppressive Medications in Non-Hematemesis GIB Patients Minimizes the Risk of Peptic Ulcers as theSource of BleedSalmaan Jawaid, MD, Neil Marya, MD, Christopher Marshall, MD,Anupam Singh, MD, Gregory Volturo, MD, Bilal Gondal, MD, JosephCharpentier, DO, Louise Maranda, PhD, Anne Foley, BA, CCRC, DavidCave, MD, PhD, University of Massachusetts Medical Center, Worcester,MA, University of Massachusetts Medical School, Worcester, MAP1023. The Effect of Dual Antiplatelet Therapy on the Severity of LowerIntestinal BleedingNeal Carlin, MD, Walid Baddoura, MD, FACG, Fady Asslo, MD, SaintMichael’s Medical Center, Newark, NJ, Saint Joseph’s Regional MedicalCenter, Patterson, NJP1024. The Inappropriate Use of Fecal Immunochemical Testing in aSafety-Net HospitalJ. Christie Heller, MD, Angela Keniston, MSPH, Joel Levine, MD,Gastroenterology and Hepatology, Denver Health, Denver, COP1025. 30-Day Readmission After Admission for Alcoholic Hepatitis:Prevalence and Impact on OutcomeKaely Bade, MD, Sujan Ravi, MD, Ashwani Singal, MD, MS, Universityof Alabama at Birmingham, Birmingham, ALP1026. Esophagogastroduodenoscopy Indications: Are We Following theNew Guidelines?Caroline Soyka, DO, Priyam Tripathi, MD, MPH, Gregory Cooper, MD,FACG, University Hospitals Case Medical Center, Cleveland, OHP1027. A Quality Improvement Intervention Significantly ImprovedInfluenza and Pneumococcal Vaccination Rates in Patients WithInflammatory Bowel Disease (IBD)Jason Reich, MD, Daniel Zanchetti, MD, Sharmeel Wasan, MD, HannahMiller, MD, Ansu Noronha, MD, Eileen Ardagna, RN, Brian Jacobson,MD, MPH, Francis Farraye, MD, MSc, Section of Gastroenterology,Boston Medical Center, Boston, MAP1028. Association of Histology and Location of Malignant ColonicPolyps: A SEER database AnalysisXi Zheng, MD, PhD, Public Health, Weill Cornell Medical College, NewYork, NYP1029. Impact of Active H. pylori Infection on Degree of Proteinuria in aDiabetic PopulationMiral Subhani, MD, Huafeng Shen, MD, Mitanshu Shah, MD, SethLipka, MD, Dhyan Rajan, MD, Paul Mustacchia, MD, MBA, NassauUniversity Medical Center, East Meadow, NY, University of SouthFlorida, Morsani College of Medicine, Tampa, FLP1030. Impact of Rapid On-Site Evaluation With CytopathologistGuidance on the Diagnostic Yield of EUS-FNA of Pancreatic LesionsTariq Hammad, MD, Usman Ahmad, MD, Yaseen Alastal, MD, OsamaAlaradi, MD, Ali Nawras, MD, FACG, Gastroenterology, University ofToledo Medical Center, Toledo, OHP1031. Hospital Readmission After Transjugular IntrahepaticPortosystemic Shunts (TIPS)Vivian Ebrahim, MD, Mazen Albeldawi, MD, Krishna Patel, MD, MenaBoules, MD, Rocio Lopez, MS, Baljendra Kapoor, MD, Maged Rizk,MD, FACG, Mohamed Yaseen Alsabbagh, MD, Naim Alkhouri, MD,FACG, Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH,Digestive Disease Institute, Cleveland Clinic, Cleveland, OH, Diagnosticand Interventional Radiology, Cleveland Clinic, Cleveland, OHP1032. Transjugular Intrahepatic Portosystemic Shunts (TIPS) in ElderlyPatients: to TIPS or not to TIPS?Vivian Ebrahim, MD, Krishna Patel, MD, Mazen Albeldawi, MD, RocioLopez, MS, Maged Rizk, MD, FACG, Mohamed Yaseen Alsabbagh,MD, Naim Alkhouri, MD, FACG, Internal Medicine, Cleveland ClinicFoundation, Cleveland, OH, Digestive Disease Institute, ClevelandClinic, Cleveland, OHP1033. Prevalence and Determinants of Topical 5-Aminosalicyclic AcidTherapy Among Veterans With Ulcerative ColitisRajesh Shah, MD, Hoda Malaty, MD, FACG, Shubhada Sansgiry, PhD,Jason Hou, MD, Baylor College of Medicine, Houston, TXP1034. Comparative Effectiveness of Biliary Brushings and Biopsies inthe Diagnosis of Malignant Biliary Strictures: A Systematic Review andMeta-analysisUdayakumar Navaneethan, MD, Basile Njei, MD, VennisvasanthLourdusamy, MD, Madhusudhan Sanaka, MD, FACG, The ClevelandClinic, Cleveland, OH, University of Connecticut, Connecticut, CTP1035. Compliance With American Gastroenterological AssociationInflammatory Bowel Disease Quality MeasuresSana Siddique, MD, Joseph Feuerstein, MD, Natalia Castillo, MD,Jeffrey Lewandowski, MD, FACG, Kerry Geissler, RN, FACG, ManuelMartínez Vazquez, MD, FACG, Daniel Leffler, MD, MS, FACG, BobThukral, MD, PhD, FACG, Adam Cheifetz, MD, FACG, Medicine, MountAuburn Hospital, Cambridge, MA, Beth Israel Deaconess MedicalCenter, Boston, MA, University Hospital, Monterrey, Mexico, Universityof Illinois, Chicago, ILP1036. A High Body Mass Index (BMI) Is Associated With IncrementalHealth Care Utilization and Surgical Complications in PatientsUndergoing Colorectal Cancer Surgery2014 ACG Presidential Poster AwardHisham Hussan, MD, Darrell Gray, MD, MPH, Cheng Zhang, MD,PhD, Alice Hinton, PhD, Somashekar Krishna, MD, MPH, SheetalSharma, MBBS, Darwin Conwell, MD, MS, Peter Stanich, MD, Sectionof Intestinal Neoplasia and Hereditary Polyposis (INHP), Department ofGastroenterology, Hepatology and Nutrition, The Ohio State UniversityMedical Center, Columbus, OH, Department of Gastroenterology,Hepatology and Nutrition, The Ohio State University Medical Center,Columbus, OH, Division of Biostatistics, College of Public Health, TheOhio State University, Columbus, OHP1037. Type 2 Diabetes Mellitus Increases Economic Burden ofColorectal Cancer SurgeryHisham Hussan, MD, Darrell Gray, MD, MPH, Somashekar Krishna,MD, MPH, Alice Hinton, PhD, Jeffery Groce, MD, Darwin Conwell, MD,MS, Peter Stanich, MD, Section of Intestinal Neoplasia and HereditaryPolyposis (INHP), Department of Gastroenterology, Hepatology andNutrition, The Ohio State University Medical Center, Columbus, OH,Department of Gastroenterology, Hepatology and Nutrition, The OhioState University Medical Center, Columbus, OH, Division of Biostatistics,College of Public Health, The Ohio State University, Columbus, OHINFLAMMATORY BOWEL DISEASEP1038. Understanding Attitudes, Perceptions, and Beliefs AboutUlcerative Colitis Among Gastroenterologists: Phase 1 Survey ResultsKaren Lasch, MD, Lyann Ursos, PhD, Stephen Liu, PharmD, ReemaMody, PhD, Kristen Concialdi, Marco DiBonaventura, PhD, JulieLeberman, PhD, Marla Dubinsky, MD, Takeda PharmaceuticalsInternational, Inc., Deerfield, IL, Kantar Health, New York, NY,Independant Consultant, Fairless Hills, PA, Department of Pediatrics,Pediatric Inflammatory Bowel Disease Center, and ImmunobiologyResearch Institute, Cedars-Sinai Medical Center, Los Angeles, CAFor more information on ACG 2014 and to register, visit www.acgmeetings.gi.org.84
Poster Presentations – Monday, October 20, 10:30 am - 4:00 pmP1039. No Increase in Serious or Mild Infectious Complications ofImmunosuppression in an Office-Based IBD Population: A ProspectiveStudyChris Shepela, MD, MS, Justin Howard, MD, Katherine Janssen, MD,Kathleen Barrett, CNP, GI, Health Partners, Saint Paul, MNP1040. Anti-TNF Agents Prevent Endoscopic and Clinical Recurrence ofCrohn’s Disease After Surgical Resection: A Meta-AnalysisHoussam Mardini, MD, MBA, MPH, FACG, Alla Grigorian, MD, PhD,Lisbeth Selby, MD, Terrence Barrett, MD, University of Kentucky,Lexington, KYP1041. Response Rates to Anti-TNF Biologic Therapy After Failure of aPrior Biologic: A Retrospective Analysis of a Single Center’s ExperienceWilliam Ferges, MD, Geoffrey You, MD, Muhammad Shafqet, MD,Qasim Salimi, MD, Daniel Schaer, MD, Eleazer Yousefzadeh, MD, KironDas, MD, PhD, FACG, S. Devi Rampertab, MD, FACG, Rutgers - RobertWood Johnson Medical School, New Brunswick, NJP1042. Side Effect Profiles of Anti-TNF Biologics in the Treatment ofInflammatory Bowel Disease: Experience of a Single Crohn’s and ColitisCenterWilliam Ferges, MD, Qasim Salimi, MD, Geoffrey You, MD, MuhammadShafqet, MD, Daniel Schaer, MD, Kiron Das, MD, PhD, FACG, S. DeviRampertab, MD, FACG, Rutgers - Robert Wood Johnson MedicalSchool, New Brunswick, NJP1043. Clinical Predictors of a Poor Response to Anti-TNF BiologicTherapy for Inflammatory Bowel DiseaseWilliam Ferges, MD, Muhammad Shafqet, MD, Qasim Salimi, MD,Geoffrey You, MD, Daniel Schaer, MD, Kiron Das, MD, PhD, FACG, S.Devi Rampertab, MD, FACG, Rutgers - Robert Wood Johnson MedicalSchool, New Brunswick, NJP1044. Analysis of Risk Factors for Avascular Necrosis in InflammatoryBowel DiseaseSiddhant Yadav, MD, Scott Harmsen, MS, Edakkanambeth VarayilJithinraj, MD, Kevin Karls, MD, William Tremaine, MD, FACG, EdwardLoftus, MD, FACG, Gastroenterology and Hepatology, Mayo Clinic,Rochester, MN, Mid-Dakota Clinic, Bismarck, NDP1045. Incidence and Outcomes of Home Parenteral Nutrition in PatientsWith Crohn’s Disease in Olmsted County, MinnesotaSiddhant Yadav, MD, Edakkanambeth Varayil Jithinraj, MD, ScottHarmsen, MS, William Tremaine, MD, FACG, Ryan Hurt, MD, PhD,Edward Loftus, MD, FACG, Gastroenterology and Hepatology, MayoClinic, Rochester, MNP1046. The C. difficile Relapse Rate Is Low in IBD Patients Who HaveMetronidazole or Vancomycin as Initial TherapyLilani Perera, MD, Amar Dodda, MD, Yelena Zadvornova, Daniel Stein,MD, Amar Naik, MD, Kari Best, PA-C, Kathleen Idstein, PA-C, BensonMassey, MD, Medicine, Medical College of Wisconsin, Milwaukee, WIP1047. Predictors of Satisfaction With Life Among Adult Patients WithEstablished Crohn’s DiseaseOrly Sarid, PhD, Vered Slonim-Navo, PhD, Michael Friger, PhD, HillelVardi, MS, Doron Schwartz, MD, Daniela Munteau, MD, Vitaly Dizengof,MD, Alex Moshkelo, MD, Alex Rozental, MD, Gil Ben Yaakov, MD,Pavel Krugliak, MD, Naim Abu Freha, MD, Leslie Eidelman, MD, NavaGaspar, MD, Alex Fich, MD, Dan Greenberg, PhD, Shmuel Odes, MD,Social Work, Ben-Gurion University of the Negev, Beer Sheva, Israel,Public Health, Ben-Gurion University of the Negev, Beer Sheva, Israel,Gastroenterology and Hepatology, Soroka Medical Center, Beer Sheva,Israel, Health Systems Management, Ben-Gurion University of theNegev, Beer Sheva, Israel, Gastroenterology, Ben-Gurion University ofthe Negev, Beer Sheva, IsraelP1048. Imbalanced Intestinal Microbiota in Treatment-Naïve PatientsWith Inflammatory Bowel Disease by a Metagenomic ApproachYoulian Zhou, MS, Yan He, PhD, Pu Wang, PhD, Ting Zhang, PhD,Jiasheng Tan, MS, Minyi Lin, MS, Yunsheng Yang, PhD, Bo Jiang,PhD, Hongwei Zhou, PhD, Ye Chen, PhD, Gastroenterology.NanfangHospital, Southern Medical University, Guangzhou, China, Departmentof Environmental Health,School of Public Health and Tropical Medicine,Southern Medical University, Guangzhou, China, Institute of DigestiveDiseases, Chinese PLA General Hospital, Beijing, ChinaP1049. SHIELD 4 Phase 3 Clinical Trial With Orally Administered CCR9Inhibitor Vercirnon in Crohn’s DiseaseSatish Keshav, MD, PhD, Thomas Schall, PhD, Pirow Bekker, MD, PhD,John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom,ChemoCentryx, Inc., Mountain View, CAP1050. Predictors of Hospitalization in Patients With Moderately toSeverely Active Ulcerative Colitis From ULTRA 1 and ULTRA 2Brian Feagan, MD, William Sandborn, MD, Walter Reinisch, MD,Subrata Ghosh, MD, Anne Robinson, MD, Andreas Lazar, MD, QianZhou, PhD, Martha Skup, MD, Roopal Thakkar, MD, University ofWestern Ontario, London, ON, Canada, University of California SanDiego, La Jolla, CA, McMaster University, Hamilton, ON, Canada,University of Calgary, Calgary, AB, Canada, AbbVie Inc, NorthChicago, IL, AbbVie Deutschland GmbH and Co. KG, Ludwigshafen,GermanyP1051. Patients With Refractory Crohn’s Disease Successfully TreatedWith UstekinumabKimberly Harris, MD, Sara Horst, MD, Akash Gadani, MD, AnneNohl, PA, Kimberly Annis, PA, Caroline Duley, NP, Dawn Beaulieu,MD, Leyla Ghazi, MD, David Schwartz, MD, Vanderbilt UniversityMedical Center, Nashville, TN, University of Maryland MedicalCenter, Baltimore, MDP1052. Efficacy of High-Dose Versus Low-Dose Methotrexate inCombination Therapy for Inflammatory Bowel DiseaseRuben Colman, MD, David Rubin, MD, FACG, IBD Center, Universityof Chicago Medicine, Chicago, ILP1053. POSTER WITHDRAWNP1054. Effects of Increased Vedolizumab Dosing Frequency on DiseaseActivity in Ulcerative Colitis and Crohn’s DiseaseBruce Sands, MD, FACG, Marla Dubinsky, MD, Séverine Vermeire, MD,PhD, Serap Sankoh, PhD, Maria Rosario, PhD, Catherine Milch, MD,Icahn School of Medicine at Mount Sinai, New York, NY, Cedars-SinaiMedical Center, Los Angeles, CA, University Hospital Gasthuisberg,Leuven, Belgium, Takeda Pharmaceuticals International Co.,Cambridge, MAP1055. Underestimation of Disease Severity in Patients WithInflammatory Bowel Disease by Physicians in Case Study SurveyTauseef Ali, MD, A Burak Ozbay, BPharm, MBA, PhD, Martha Skup,PhD, Song Wang, PhD, Brittany Gentile, PhD, Danielle Cohen, MPH,Roopal Thakkar, MD, Jingdong Chao, PhD, University of Oklahoma,Oklahoma City, OK, AbbVie Inc., North Chicago, IL, ICON Plc, SanFrancisco, CAP1056. Physician Survey to Assess Severity Criteria for Patients WithInflammatory Bowel DiseaseTauseef Ali, MD, Martha Skup, PhD, A Burak Ozbay, BPharm, MBA,PhD, Song Wang, PhD, Brittany Gentile, PhD, Danielle Cohen, MPH,Roopal Thakkar, MD, Jingdong Chao, PhD, University of Oklahoma,Oklahoma, OK, AbbVie Inc., North Chicago, IL, ICON Plc, SanFrancisco, CAP1057. Eating Patterns and Disease Activity in Patients WithInflammatory Bowel DiseaseErsilia DeFilippis, BA, Saniya Tabani, BA, Ryan Warren, BA, ColleenWebb, MS, RD, Priyanka Patel, MS, Fatiha Chabouni, MD, PaulChristos, DrPH, MS, Brian Bosworth, MD, FACG, Ellen Scherl,MD, FACG, Weill Cornell Medical College, New York, NY, New YorkPresbyterian-Weill Cornell Medical Center, New York, NYPOSTERSMONDAY85For more information on ACG 2014 and to register, visit www.acgmeetings.gi.org.
- Page 6 and 7:
Featured LecturesDavid Sun LectureT
- Page 8:
Special EventsThere are numerous op
- Page 12 and 13:
ACG's 2014 Optional Friday Coursesa
- Page 15 and 16:
asge-sponsored endoscopy courseACG'
- Page 18:
Optional Friday Courses / ACG's 201
- Page 21 and 22:
ACG's 2014 Postgraduate Course - Sa
- Page 23 and 24:
ACG's 2014 Postgraduate Course - Su
- Page 25 and 26:
ACG's 2014 Annual Scientific Meetin
- Page 27 and 28:
Annual Scientific Meeting Agenda -
- Page 29 and 30:
Annual Scientific Meeting Agenda -
- Page 31 and 32:
Annual Scientific Meeting Agenda -
- Page 33 and 34:
Annual Scientific Meeting Agenda -
- Page 35 and 36: Annual Scientific Meeting Agenda -
- Page 37 and 38: Annual Scientific Meeting Agenda -
- Page 39 and 40: Annual Scientific Meeting - Faculty
- Page 41 and 42: Poster PresentationsSunday, October
- Page 43 and 44: Poster Presentations - Sunday, Octo
- Page 45 and 46: Poster Presentations - Sunday, Octo
- Page 47 and 48: Poster Presentations - Sunday, Octo
- Page 49 and 50: Poster Presentations - Sunday, Octo
- Page 51 and 52: Poster Presentations - Sunday, Octo
- Page 53 and 54: Poster Presentations - Sunday, Octo
- Page 55 and 56: Poster Presentations - Sunday, Octo
- Page 57 and 58: Poster Presentations - Sunday, Octo
- Page 59 and 60: Poster Presentations - Sunday, Octo
- Page 61 and 62: Poster Presentations - Sunday, Octo
- Page 63 and 64: Poster Presentations - Sunday, Octo
- Page 65 and 66: Poster Presentations - Sunday, Octo
- Page 67 and 68: Poster Presentations - Sunday, Octo
- Page 69 and 70: Poster Presentations - Monday, Octo
- Page 71 and 72: Poster Presentations - Monday, Octo
- Page 73 and 74: Poster Presentations - Monday, Octo
- Page 75 and 76: Poster Presentations - Monday, Octo
- Page 77 and 78: Poster Presentations - Monday, Octo
- Page 79 and 80: Poster Presentations - Monday, Octo
- Page 81 and 82: Poster Presentations - Monday, Octo
- Page 83 and 84: Poster Presentations - Monday, Octo
- Page 85: Poster Presentations - Monday, Octo
- Page 89 and 90: Poster Presentations - Monday, Octo
- Page 91 and 92: Poster Presentations - Monday, Octo
- Page 93 and 94: Poster Presentations - Monday, Octo
- Page 95 and 96: Poster Presentations - Tuesday, Oct
- Page 97 and 98: Poster Presentations - Tuesday, Oct
- Page 99 and 100: Poster Presentations - Tuesday, Oct
- Page 101 and 102: Poster Presentations - Tuesday, Oct
- Page 103 and 104: Poster Presentations - Tuesday, Oct
- Page 105 and 106: Poster Presentations - Tuesday, Oct
- Page 107 and 108: Poster Presentations - Tuesday, Oct
- Page 109 and 110: Poster Presentations - Tuesday, Oct
- Page 111 and 112: Poster Presentations - Tuesday, Oct
- Page 113 and 114: Poster Presentations - Tuesday, Oct
- Page 115 and 116: Poster Presentations - Tuesday, Oct
- Page 117 and 118: Poster Presentations - Tuesday, Oct
- Page 119 and 120: Poster Presentations - Tuesday, Oct
- Page 121 and 122: Poster Presentations - Tuesday, Oct
- Page 123 and 124: General InformationAccreditationThe
- Page 125 and 126: ACG Auxiliary Events and ToursAuxil
- Page 127 and 128: ACG 2014 Registration FormMail to:
- Page 129 and 130: Exhibit HallThe science and technol
- Page 131 and 132: Child Care Registration FormThe Ame
- Page 133: For ACG 2014 Annual Postgraduate Co